Cargando…

The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection

PURPOSE: We investigated the influence of amoxicillin pre-exposure on treatment outcomes, Chlamydia trachomatis (CT) culture, the presence of drug-resistant genes, minimum inhibitory concentrations (MICs), and fractional inhibitory concentrations (FICs) in CT clinical strains. Additionally, we explo...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Cong, Liao, Mingyi, Wang, Mei, Zhao, Leran, Li, Longnian, Ye, Xiaoying, Yang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257477/
https://www.ncbi.nlm.nih.gov/pubmed/37305735
http://dx.doi.org/10.2147/IDR.S410410
_version_ 1785057310495735808
author You, Cong
Liao, Mingyi
Wang, Mei
Zhao, Leran
Li, Longnian
Ye, Xiaoying
Yang, Tao
author_facet You, Cong
Liao, Mingyi
Wang, Mei
Zhao, Leran
Li, Longnian
Ye, Xiaoying
Yang, Tao
author_sort You, Cong
collection PubMed
description PURPOSE: We investigated the influence of amoxicillin pre-exposure on treatment outcomes, Chlamydia trachomatis (CT) culture, the presence of drug-resistant genes, minimum inhibitory concentrations (MICs), and fractional inhibitory concentrations (FICs) in CT clinical strains. Additionally, we explored the effect of different antimicrobial combinations on CT. PATIENTS AND METHODS: Clinical data of 62 patients with CT infection were recorded. Of these, 33 had pre-exposure to amoxicillin and 29 did not. Among patients with pre-exposure, 17 received azithromycin and 16 received minocycline. Among the patients without pre-exposure, 15 received azithromycin and 14 received minocycline. All patients underwent microbiological cure follow-ups one month after completing the treatment. 23S rRNA gene mutations, acquisition of tet(M) and tet(C) were detected using reverse transcription PCR (RT-PCR) and PCR, respectively. The MICs and FICs of azithromycin, minocycline, and moxifloxacin, alone or in combination, were determined using the microdilution and checkerboard methods, respectively. RESULTS: More cases of treatment failure occurred in pre-exposed patients, in both treatment groups (P <0.05). No 23S rRNA gene mutations or tet(M) and tet(C) acquisitions were found. More inclusion bodies were cultured from patients without amoxicillin pre-exposure than from those with pre-exposure (P <0.0001). The MICs of all antibiotics were higher in pre-exposed patients than in those without pre-exposure (P <0.01). The FICs of azithromycin plus moxifloxacin were lower than those of the other antibiotic combinations (P <0.0001). The synergy rate of azithromycin plus moxifloxacin was significantly higher than those of azithromycin plus minocycline and minocycline plus moxifloxacin (P <0.001). The FICs of all antibiotic combinations were comparable between isolates from the two patient groups (all P >0.05). CONCLUSION: Pre-exposure to amoxicillin in CT patients may inhibit CT growth and decrease sensitivity of CT strains to antibiotics. Azithromycin plus moxifloxacin may be a promising treatment regimen for genital CT infections with treatment failure.
format Online
Article
Text
id pubmed-10257477
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102574772023-06-11 The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection You, Cong Liao, Mingyi Wang, Mei Zhao, Leran Li, Longnian Ye, Xiaoying Yang, Tao Infect Drug Resist Original Research PURPOSE: We investigated the influence of amoxicillin pre-exposure on treatment outcomes, Chlamydia trachomatis (CT) culture, the presence of drug-resistant genes, minimum inhibitory concentrations (MICs), and fractional inhibitory concentrations (FICs) in CT clinical strains. Additionally, we explored the effect of different antimicrobial combinations on CT. PATIENTS AND METHODS: Clinical data of 62 patients with CT infection were recorded. Of these, 33 had pre-exposure to amoxicillin and 29 did not. Among patients with pre-exposure, 17 received azithromycin and 16 received minocycline. Among the patients without pre-exposure, 15 received azithromycin and 14 received minocycline. All patients underwent microbiological cure follow-ups one month after completing the treatment. 23S rRNA gene mutations, acquisition of tet(M) and tet(C) were detected using reverse transcription PCR (RT-PCR) and PCR, respectively. The MICs and FICs of azithromycin, minocycline, and moxifloxacin, alone or in combination, were determined using the microdilution and checkerboard methods, respectively. RESULTS: More cases of treatment failure occurred in pre-exposed patients, in both treatment groups (P <0.05). No 23S rRNA gene mutations or tet(M) and tet(C) acquisitions were found. More inclusion bodies were cultured from patients without amoxicillin pre-exposure than from those with pre-exposure (P <0.0001). The MICs of all antibiotics were higher in pre-exposed patients than in those without pre-exposure (P <0.01). The FICs of azithromycin plus moxifloxacin were lower than those of the other antibiotic combinations (P <0.0001). The synergy rate of azithromycin plus moxifloxacin was significantly higher than those of azithromycin plus minocycline and minocycline plus moxifloxacin (P <0.001). The FICs of all antibiotic combinations were comparable between isolates from the two patient groups (all P >0.05). CONCLUSION: Pre-exposure to amoxicillin in CT patients may inhibit CT growth and decrease sensitivity of CT strains to antibiotics. Azithromycin plus moxifloxacin may be a promising treatment regimen for genital CT infections with treatment failure. Dove 2023-06-06 /pmc/articles/PMC10257477/ /pubmed/37305735 http://dx.doi.org/10.2147/IDR.S410410 Text en © 2023 You et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
You, Cong
Liao, Mingyi
Wang, Mei
Zhao, Leran
Li, Longnian
Ye, Xiaoying
Yang, Tao
The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection
title The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection
title_full The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection
title_fullStr The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection
title_full_unstemmed The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection
title_short The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection
title_sort effect of amoxicillin pre-exposure on treatment outcomes and antimicrobial susceptibility in patients with urogenital chlamydia trachomatis infection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257477/
https://www.ncbi.nlm.nih.gov/pubmed/37305735
http://dx.doi.org/10.2147/IDR.S410410
work_keys_str_mv AT youcong theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT liaomingyi theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT wangmei theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT zhaoleran theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT lilongnian theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT yexiaoying theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT yangtao theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT youcong effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT liaomingyi effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT wangmei effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT zhaoleran effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT lilongnian effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT yexiaoying effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection
AT yangtao effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection